Balaam's design [General Sta­tis­tics]

posted by Helmut Homepage – Vienna, Austria, 2009-09-23 14:47 (6110 d 03:09 ago) – Posting: # 4236
Views: 9,010

Dear Raveendranath!

❝ […] Balaam's design […] can we calculate Intra CV for Reference and Intra CV for Test separately?


Yes, because you have repeated administrations in the the first two sequences.

❝ If yes plz tell me the ANOVA design.


You gave the design already yourself. :confused:
I would guess that for FDA and EMEA applications you are on slippery ground (they expect 3- or 4-period replicate designs). On the other hand ANVISA states Balaam’s design in their guideline. Don’t ask me about sample size estimations – no idea…

For the evaluation see:

S-C Chow and J-p Liu
Design and Analysis of Bioavailability and Bioequivalence Studies
Marcel Dekker, New York, pp 257-266 (3rd ed. 2008)


Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
23,654 posts in 4,992 threads, 1,571 registered users;
122 visitors (0 registered, 122 guests [including 18 identified bots]).
Forum time: 17:56 CEST (Europe/Vienna)

Always listen to experts.
They’ll tell you what can’t be done and why.
Then do it.    Robert A. Heinlein

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5